Genomic Features of Newly Diagnosed Large B-cell Lymphoma with or without Subsequent Disease Progression.

ABSTRACT:

Significance

Genomic features of LBCL that can be detected by clinical laboratory assays may predict for resistance to first-line immunochemotherapy, as well as support the exploration of genomic features as biomarkers of response to therapies which could be offered to patients who experience disease progression.

SUBMITTER: Landsburg DJ 

PROVIDER: S-EPMC11558615 | biostudies-literature | 2024 Nov

REPOSITORIES: biostudies-literature